HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

PURPOSE: We examined associations between tumor characteristics (human epidermal growth factor receptor 2 [HER2] protein expression, HER2 gene and chromosome 17 copy number, hormone receptor status) and disease-free survival (DFS) of patients in the N9831 adjuvant trastuzumab trial. PATIENTS AND MET...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Perez, Edith A., Reinholz, Monica M., Hillman, David W., Tenner, Kathleen S., Schroeder, Matthew J., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Harris, Lyndsay N., Gralow, Julie R., Dueck, Amylou C., Ketterling, Rhett P., Ingle, James N., Lingle, Wilma L., Kaufman, Peter A., Visscher, Daniel W., Jenkins, Robert B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2010
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954132/
https://ncbi.nlm.nih.gov/pubmed/20697084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.2154
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi